Navigation Links
NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
Date:9/14/2010

NanoPass Technologies Ltd. and Elcam Medical Enter Into a... -- REHOVOT and KIBBUTZ BAR'AM, Israel, September 14, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Nanotechnology, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts, Joint Ventures, Clinical Trials & Medical Discoveries Click to view news release full screen  

NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership

 

REHOVOT and KIBBUTZ BAR'AM, Israel, September 14, 2010 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a privately held company that develops novel microneedle solutions for painless delivery of drugs and vaccines, announced today that it has recently secured a strategic investment and manufacturing agreement with a leading medical device manufacturer, Elcam Medical ("Elcam"). Existing investors including Ofer Hi Tech and D Partners, also participated in the round.

As part of the investment, Mr. Ehud Raivitz, Elcam's CEO, and Mr. Ilan Neugarten of D Partners, will join NanoPass's Board of Directors. Ehud Raivitz remarked, "We are happy to enter into this partnership with NanoPass. I have been impressed by their innovative technology, positive clinical data and achievements. I look forward to leveraging Elcam's capabilities in production and engineering for the mutual benefit of both companies. The collaboration with NanoPass will enable Elcam to provide its customers with access to the most advanced intradermal delivery technology that can address their needs in various applications."

Dr. Yotam Levin, Chief Executive Officer of NanoPass, commented, "We are excited to enter into this strategic partnership with Elcam, a long time supplier of disposable medical products for the medical and pharma industries. We see a significant synergy between our companies. Along with the regulatory approvals we have recently obtained from the FDA and other regulatory bodies, securing a reliable and highly experienced manufacturer is a key component towards full commercialization of our products. The investment will allow NanoPass to develop additional pharmaceutical clients and prepare for market launch."

About NanoPass Technologies Ltd.

NanoPass Technologies was founded by Dr. Shuki Yeshurun under the auspices of the Naiot Technological Incubator. The company is backed by prominent Israeli and US investors including Ofer Hi Tech, D Partners, WFD Ventures, and more recently, Elcam Medical.

About NanoPass's MicronJet Device

MicronJet is a microneedle-based device for ID delivery of vaccines and drugs. The device allows for consistent, reliable, and simple delivery of the drugs directly into the skin. MicronJet has proven efficacy and safety in multiple applications including seasonal flu vaccines, insulin and lidocaine. MicronJet is approved for marketing in various leading territories.

NanoPass has recently concluded the world's first intradermal h1n1 pandemic flu vaccine study, demonstrating equivalent immunogenicity to intramuscular delivery using 20% of the dose. In other clinical trials conducted by NanoPass and third parties, it has been shown that injecting a seasonal influenza vaccine directly into the skin allows for the reduction of the dose required for the same immune response ("dose sparing"). Further, using an equivalent dose may actually increase a vaccine's immunogenicity.

About Elcam Medical

Elcam Medical (Bar-Am, Israel) is a leading worldwide OEM supplier, servicing the medical industry, specializing in the areas of Fluid Management, Vital Signs Monitoring and Drug Delivery.

Contact: Yotam Levin +972-8-9462905 +972-523-392727 yotam@nanopass.com
'/>"/>

SOURCE NanoPass Technologies LTD.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Energy technologies not enough to sufficiently reduce carbon emissions, NYUs Hoffert concludes
2. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
3. Reportlinker Adds Proteomics - Technologies, Markets and Companies
4. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
5. Statement From Sicel Technologies, Inc.
6. Medisafe 1 Technologies Announces 1-5 Stock Dividend
7. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
8. TriLink BioTechnologies to Sponsor Take Me Out to the Ballgame, a SAY San Diego Event Benefiting San Diego Families in Need
9. Life Technologies and SG Biofuels Complete Sequence of Jatropha Genome
10. Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives
11. Looking to leap forward on laser and photodetector technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... a returning partner of the Amgen Tour of California , ... of the men,s and women,s events for the next five editions ... of California will mark the start of ... cycling teams in the world racing from Northern to ... from Heart Disease TM Women,s Race empowered with SRAM ...
(Date:2/21/2017)... Feb. 21, 2017   Invitae Corporation (NYSE: ... today announced that members of the company,s management team ... Health Care Conference on Monday, March 6, 2017 at ... Boston, Massachusetts . ... accessed by visiting the investors section of the company,s ...
(Date:2/20/2017)... BIOA ) announced today that Jean-Francois Huc has ... has been named President, effective immediately.  In his ... the construction, start-up and operation of the manufacturing plant in ...  Fabrice has also been extensively involved in the negotiations with CJ ... ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... metal detection solutions for the food and pharmaceutical processing and packaging industries, was ... to the manufacturer that has done the most or taken the most innovative ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... LONG BEACH, New York , February 7, 2017 ... formerly known as ID Global Solutions Corporation [OTC: IDGS], ... identification, identity management and electronic transaction processing services, is ... a reorganization of the Company. Effective January ... Chairman of the Board of Directors, CEO and President. ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):